Marshall Wace’s CapsoVision Inc CV Stock Holding History

Marshall Wace’s Portfolio CV Stock Details CV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,925	Closed	-$62.6K	–	3625
2025 Q3	$62.6K	Buy	+12,925	New	+$54.2K	﹤0.01%	2708

Other funds holding CV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

AWA

Alaska Wealth Advisors Anchorage, Alaska $833M AUM 12.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's CV Position: Q4 2025 in Review

Marshall Wace sold out of CapsoVision Inc (CV) in Q4 2025, closing a stake of 12,925 shares — an estimated $62.6K sold.

Marshall Wace first reported a position in CV in Q3 2025 and held it in 1 quarter. The position peaked at $62.6K in Q3 2025. 32 funds tracked by Wall St. Rank hold CV as of Q4 2025.

Marshall Wace reported no remaining CapsoVision Inc position as of Q4 2025 after selling out during the quarter.
Marshall Wace sold 12,925 CapsoVision Inc shares in Q4 2025, an estimated $62.6K.
Marshall Wace first reported a position in CapsoVision Inc in Q3 2025 and held it in 1 quarter.
Marshall Wace's CapsoVision Inc position peaked at $62.6K in Q3 2025.
32 funds tracked by Wall St. Rank held CapsoVision Inc as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.